Key Highlights
- UPSA's commitment to quality and innovation is evident in its extensive product line and global reach.
- The company's strategic location in Agen allows it to efficiently distribute its products worldwide.
- UPSA's dedication to its 'Made in France' ethos and its role as a major employer in the Lot-et-Garonne region underscore its importance to the local economy.
- The company's focus on five therapeutic areas ensures it addresses a wide range of common health issues.
- UPSA's strong presence in over 60 countries highlights its global impact and commitment to improving patient care worldwide.
About UPSA
UPSA is a pharmaceutical company founded in 1935, dedicated to improving the quality of life through its range of medications and medical devices. With a strong focus on pain relief, fever management, and other common ailments, UPSA serves patients from infants to the elderly. The company operates one of Europe's largest pharmaceutical manufacturing sites in Agen, France, and exports nearly 40% of its production to over 60 countries. UPSA is committed to its French heritage and employs over 1,500 people directly, with an additional 3,500 jobs supported in the region.
UPSA specializes in five therapeutic areas: pain and fever, ear, nose, and throat (ENT) and respiratory conditions, digestive health, sleep disorders, and vitality. The company's products are designed to address everyday health issues, making it a trusted name in healthcare. UPSA's commitment to quality and innovation is reflected in its extensive product line and global reach.
The company's dedication to its 'Made in France' ethos and its role as a major employer in the Lot-et-Garonne region underscore its importance to the local economy and its global impact. UPSA's strategic location in Agen allows it to efficiently distribute its products worldwide, ensuring that patients everywhere have access to its high-quality medications.
Leadership Team
Tip: The CEO isn't always your best path in. Data Surfer finds the champions and influencers who actually drive purchasing decisions.
Company Facts
| Ownership Private Company |
Office Locations
- Agen, France
Why Contact UPSA?
B2B professionals should contact UPSA for partnerships in the pharmaceutical sector, particularly for products targeting pain relief, fever management, and other common ailments. UPSA's extensive product line and global distribution network offer significant opportunities for collaboration and growth.
Who Should Contact UPSA for Business?
Sales teams selling pharmaceutical products, partners interested in healthcare solutions, and recruiters seeking roles in the pharmaceutical industry should reach out to UPSA.
Categories
- Pharmaceutical
- Healthcare
- Medical Devices
- Pain Relief
- Fever Management
- ENT
- Respiratory
- Digestive Health
- Sleep Disorders
- Vitality
More Pharmaceutical Manufacturing Companies
Frequently Asked Questions
- Who is the CEO of UPSA?
- Isabelle Van Rycke is the President and Chief Executive Officer (CEO) of UPSA.
- What does UPSA do?
- UPSA is a pharmaceutical company that develops and manufactures drugs, medical devices, and food supplements, with a focus on pain treatment, cough and cold medicines, and nasal sprays.
- How many employees does UPSA have?
- UPSA has a total of 1,954 employees.
- Where is UPSA headquartered?
- The company is headquartered in Rueil Malmaison, France, with its largest industrial site located in Agen.
- What industry is UPSA in?
- UPSA operates in Pharmaceutical Manufacturing, Healthcare Solutions, Medical Devices.
- When was UPSA founded?
- UPSA was founded in 1935.
- Is UPSA still active?
- Yes, UPSA was verified as an active company on February 2, 2026. Data Surfer regularly validates company information to ensure accuracy.
- How do I sell to UPSA?
- Research UPSA's priorities and goals, identify the right decision makers and champions, monitor for buying signals, and reach out at the right time with verified contact details. Learn how Data Surfer helps.
Ready to Sell to UPSA?
Get qualified leads in 10 minutes. Research prospects, find decision makers, and monitor for the perfect moment to reach out.
Last verified: February 2, 2026
Backed by startup programs from
Connect with UPSA